Metraipolis › archive › dc_67dcabbd9f41

Sequencing approaches in hereditary cancer testing: strengths, limitations and future directions — Europe PMC PMID:41851262

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41851262
DOI
10.1038/s41431-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-04T06:47:00.772Z
SHA-256 of the archived text
4614c28dfde6fbb2a05d9ef839142bd71806944db6510c23837c539ae63a40d4
Stable URL of this page
https://metraipolis.com/documento/dc_67dcabbd9f41

How to cite

Sequencing approaches in hereditary cancer testing: strengths, limitations and future directions — Europe PMC PMID:41851262 — Europe PMC (en), https://europepmc.org/article/MED/41851262 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_67dcabbd9f41 (Metraipolis archive dc_67dcabbd9f41, sha256 4614c28dfde6fbb2a05d9ef839142bd71806944db6510c23837c539ae63a40d4)
BibTeX
@misc{dc67dcabbd9f41,
  title = {Sequencing approaches in hereditary cancer testing: strengths, limitations and future directions — Europe PMC PMID:41851262},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41851262},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_67dcabbd9f41; sha256 4614c28dfde6fbb2a05d9ef839142bd71806944db6510c23837c539ae63a40d4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41851262. Agents can read the archived copy with the MCP tool read_document.